Content Currently Unavailable
Sustainability Is the New Survival Strategy
Green issues shouldn’t be treated as “woke.” Instead, they should be seen as pharma’s license to operate. Three industry experts discuss.
Content Currently Unavailable
False
Green issues shouldn’t be treated as “woke.” Instead, they should be seen as pharma’s license to operate. Three industry experts discuss.
False
False
June 24, 2025
3 min read
Our latest news roundup reports on Eli Lilly’s Verve takeover, novel CRISPR delivery research, a growing interest in CD5-based immunotherapy, and more
July 1, 2025
4 min read
Our latest news roundup reports on thimerosal elimination, subscription termination, depression alleviation, and more
July 2, 2025
3 min read
Our latest news roundup reports on how CRISPR/Cas9 improves ASOs efficacy, Abbvie’s latest acquisition, further sickle cell disease research, and more
False
Affiliations:
Specialties:
Areas of Expertise: